Bruce Haffty Joins ACR as the Chief Medical Officer for Radiation Oncology Research

Marzia Zambon: The European Parliament Stands Up for Patients and Dedicated Health Funding

Melvin L.K. Chua: Glad to be at World Health Expo in Middle East

Alphamab Oncology Doses First Patient in Phase III JSKN003 Study for HER2-Positive Advanced Colorectal Cancer

International Childhood Cancer Day 2026: Powerful Voices, Lifesaving Hope

Oncology News, Insights, Stories by OncoDaily

Cancer World
Voices

Europe is Proving that Policy, Prevention, and Innovation Together Can Save Lives - Cancer World

VALENTINE - OncoDaily
Voices

Love, Written in Courage: Valentine’s Day Letters from the OncoDaily Followers 2026

OncoDaily Weekly
Not To Miss

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

Flash Radiotherapy: The 0.1-Second Cancer Treatment That Could Revolutionize Oncology

Cancer Care Drives Radiopharmaceuticals Market Past $21B by 2033

Carlos Rodriguez-Galindo: This is More Than Research. This is Hope in Action

PD-L1 IHC 22C3 pharmDx Guides Immunotherapy in Platinum-Resistant Ovarian Cancer

10 Must Read Posts In GI Oncology This Week

Servier and Women in Tech Global Join Forces for Future Female Leaders

HER2CLIMB-02 Trial: Where Does Tucatinib Plus T-DM1 Fit in the Modern HER2-Positive Metastatic Breast Cancer Landscape?

OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Sushmita Sen and Mark Lawler

Sushmita Sen: Evaluating Patient-Relevant Outcomes and Innovation Value

Patrizia Giannatempo: New UroFocus Episode – An Unfiltered Conversation on Burnout in Medical Practice

Maria Bolevich: Oncology Communication in the Digital Age – Insights from Marij Hillen

Ahmet Dirican: Is a New Agent Emerging for Metastatic Urothelial Carcinoma in the 2L+ Setting?

Bethel Alemayehu: Grateful to Present My Poster at the WashU Graduate Research Symposium

Giuseppe Caruso: Are PARP Inhibitors Always the Right First Move in OC?

Sewanti Limaye: An Inspiring Journey of Biomarker Discovery and Drug Discovery

FDA Approvals
FDA-Optune Pax

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

2nd Pediatric and Neonatal Palliative Care Symposium

Chance Association

25 Feb
Palliative Care

Restoring Trust in Science: Storytelling, AI, and Integrity in Scholarly Publishing

International Society for Medical Publication Professionals

26 Mar
Science

British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop

British Society of Haematology

25 Feb
British Society of Haematology

Escalation or De-Escalation? Strategies in HER2+ Breast Cancer Treatment

Sharing Progress in Cancer Care

23 Apr
Breast Cancer Treatment

38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026)

European Organisation for Research and Treatment of Cancer

18 Nov
EORTC-NCI-AACR

Immune-oncology
The Myth of Lifelong Immunotherapy

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

OncoDaily TV
Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Not To Miss
OncoDaily Weekly

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

ASH Highlights 2026: Insights from Dr Heghine Khachatryan

International Childhood Cancer Day 2026: Powerful Voices, Lifesaving Hope

International Day of Women and Girls in Science 2026

15 Posts Not To Miss from AMSTRO 2026

Oncology This Week: OncoDaily Weekly Feb 2-8, 2026

Exciting News: OncoDaily's Managing Editor Dr Elen Baloyan Releases Her 1st Mini-EP

OncoGrants
CUASF Academic–Community Collaboration Award

CUASF Academic–Community Collaboration Award

Yosemite Oncology Research Grants

Yosemite Oncology Research Grants – $18M+ in Funding Deployed

Gilbert Family Foundation Brain Tumor Initiative –

Gilbert Family Foundation Brain Tumor Initiative – NF1 High-Grade Glioma RFP 2026

UF Health Cancer Institute Catalyst Awards

UF Health Cancer Institute Catalyst Awards

UFHCI Cancer Control & Population Sciences Pilot Awards

UFHCI Cancer Control & Population Sciences Pilot Awards

CUASF-CEG Endourology Grant Program

CUASF-CEG Endourology Grant Program

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Rahat Ul Ain

Rahat Ul Ain

Oncologists Location Lahore, Pakistan
Francesco Massari

Francesco Massari

Oncologists Location Bologna, Italy
Roupen Odabashian

Roupen Odabashian

Oncologists Location Detroit, USA
Gregory Kalemkerian

Gregory Kalemkerian

Oncologists Location Ann Arbor, USA
Uirá Maíra Resende

Uirá Maíra Resende

Oncologists Location Goiânia, Brazil
Chandler Park

Chandler Park

Oncologists Location Louisville, USA
Denis Leonardo Fontes Jardim

Denis Leonardo Fontes Jardim

Oncologists Location São Paulo, Brazil
Nagashree Seetharamu

Nagashree Seetharamu

Oncologists Location Long Island, USA

Oncology Drugs
GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): Clinical Development of a Next-Generation B7-H3 Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

Anbenitamab (KN026): A Deep Dive Into a Bispecific HER2 Antibody Redefining Targeted Therapy

Iza-Bren (EGFR×HER3 ADC): A Patient-Friendly Guide To A New Cancer Treatment

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
KEYVIBE-010 Trial

KEYVIBE-010 Trial: Vibostolimab–Pembrolizumab vs Pembrolizumab in Adjuvant High-Risk Melanoma

SBRT

Biochemical Control and 2-Year Tolerability After SBRT for Localized Prostate Cancer

PATINA Trial: Palbociclib in Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

PATINA Trial: Palbociclib in Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

ARTS Trial

ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC

CATNON Trial

CATNON Final Analysis: Defining the Role of Adjuvant Temozolomide in IDH-Mutant Grade 3 Astrocytoma

JUPITER-06

JUPITER-06 Final Overall Survival and Genomic Biomarker Analysis in Advanced ESCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts